Hisskof Syrup is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the management of respiratory conditions characterized by bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator, facilitating the relaxation of bronchial smooth muscles and thereby relieving bronchospasm associated with asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway diseases. Ambroxol serves as a mucolytic agent, enhancing the clearance of mucus by breaking down the structure of mucus glycoproteins, which improves expectoration and airway patency. Guaifenesin functions as an expectorant, increasing the hydration of respiratory tract secretions, reducing mucus viscosity, and promoting effective cough to clear the airways. The synergistic action of these active ingredients makes Hisskof Syrup effective in alleviating symptoms such as cough, chest congestion, and difficulty breathing due to thick mucus. It is indicated for use in adults and children as prescribed by a healthcare professional. Caution is advised in patients with hypersensitivity to any component, and it should be used under medical supervision, particularly in individuals with cardiovascular disorders or hyperthyroidism.